The Eight Roads China Healthcare Fund has secured $250M to invest in China, while OrbiMed has $551M for investments in China and India.
The telehealth company has reported quarterly revenues of $42.9 million, representing 60% year-over-year growth.
The company reported Q1 revenues of $299 million with U.S. accounting for 52% of the figure.
BlueCross BlueShield Venture Partners invests in higi to expand the ecosystem that will personalize population health.
The company's 2016 revenues have hit $123.2 million for a growth of 59%; almost a third of all visits were in the fourth quarter.
In its year-end report, StartUp Health tracked $8 billion investments in more than 500 companies, four of which were above $400 million.
MD Start incubates companies for two to three years and takes a more active approach in the daily management of its portfolio companies.
The company will use the funds to further validate its iPad-based BAC app for use as a screening tool for cognitive decline in age-related CNS disorders.
The company will use the funds to continue scaling its technology and data science platforms, as well as expand into new markets.
The company will use the funds to accelerate the development of its imaging analytics engine and create neural networks that will use its vast imaging dataset.